Effect of omega-3 fatty acid-containing phospholipids on blood catecholamine concentrations in healthy volunteers: a randomized, placebo-controlled, double-blind trial
- PMID: 15925295
- DOI: 10.1016/j.nut.2004.07.020
Effect of omega-3 fatty acid-containing phospholipids on blood catecholamine concentrations in healthy volunteers: a randomized, placebo-controlled, double-blind trial
Abstract
Objective: We previously reported that administration of fish oil rich in docosahexaenoic acid (DHA) increased the plasma ratio of epinephrine to norepinephrine (NE) at rest in young adults who were under chronic stress and that this effect was achieved mainly through depression of NE. However, not many reports have documented the effects of eicosapentaenoic acid (EPA) and DHA on blood catecholamine levels in healthy humans. Therefore, we performed another intervention study to test their effect on catecholamines with healthy subjects under no chronic stress.
Methods: Twenty-one healthy young adults (15 men and 6 women) were randomly assigned to an omega-3 group (n = 9) or a control group (n = 12) in a double-blind manner. Twenty capsules of shellfish-derived lipids containing 762 mg of EPA plus DHA per day were administered to the omega-3 group for 2 mo. The controls took the same amount of placebo capsules. Fasting blood samples after a 30-min rest with a catheter in a forearm vein were obtained at the start and the end of the study for catecholamine measurements.
Results: EPA but not DHA concentrations in red blood cells significantly increased in the omega-3 group compared with the control group (P < 0.001). Plasma NE concentrations were significantly decreased in the omega-3 group (from 1.49 +/- 0.39 nmol/L to 1.05 +/- 0.14 nmol/L) compared with the control group (from 1.12 +/- 0.24 nmol/L to 1.39 +/- 0.32 nmol/L) with analysis of covariance (P < 0.001). The differences remained significant (P = 0.01) even after deletion of three subjects in the omega-3 group who had the highest baseline NE values and one in the control group who had the lowest baseline NE value to nullify a significant baseline differences in NE between groups.
Conclusion: This study demonstrated that EPA plus DHA supplementation lowered plasma NE concentrations in normal volunteers even at the small dose of 762 mg of EPA plus DHA per day. This effect of EPA plus DHA to lower plasma NE concentrations may be important to understand some of the effects of fish oils on diseases.
Similar articles
-
The effects of docosahexaenoic acid-rich fish oil on behavior, school attendance rate and malaria infection in school children--a double-blind, randomized, placebo-controlled trial in Lampung, Indonesia.Asia Pac J Clin Nutr. 2008;17(2):258-63. Asia Pac J Clin Nutr. 2008. PMID: 18586645 Clinical Trial.
-
Effect of fish oil supplementation on quality of life in a general population of older Dutch subjects: a randomized, double-blind, placebo-controlled trial.J Am Geriatr Soc. 2009 Aug;57(8):1481-6. doi: 10.1111/j.1532-5415.2009.02361.x. Epub 2009 Jun 22. J Am Geriatr Soc. 2009. PMID: 19549020 Clinical Trial.
-
Effect of randomized supplementation with high dose olive, flax or fish oil on serum phospholipid fatty acid levels in adults with attention deficit hyperactivity disorder.Reprod Nutr Dev. 2005 Sep-Oct;45(5):549-58. doi: 10.1051/rnd:2005045. Reprod Nutr Dev. 2005. PMID: 16188207 Clinical Trial.
-
Risk stratification by the "EPA+DHA level" and the "EPA/AA ratio" focus on anti-inflammatory and antiarrhythmogenic effects of long-chain omega-3 fatty acids.Herz. 2004 Nov;29(7):673-85. doi: 10.1007/s00059-004-2602-4. Herz. 2004. PMID: 15580322 Review.
-
Differential immunomodulation with long-chain n-3 PUFA in health and chronic disease.Proc Nutr Soc. 2007 May;66(2):237-59. doi: 10.1017/S0029665107005472. Proc Nutr Soc. 2007. PMID: 17466105 Review.
Cited by
-
Depressive symptoms, omega-6:omega-3 fatty acids, and inflammation in older adults.Psychosom Med. 2007 Apr;69(3):217-24. doi: 10.1097/PSY.0b013e3180313a45. Epub 2007 Mar 30. Psychosom Med. 2007. PMID: 17401057 Free PMC article.
-
Polyunsaturated Fatty Acids: What is Their Role in Treatment of Psychiatric Disorders?Int J Mol Sci. 2019 Oct 23;20(21):5257. doi: 10.3390/ijms20215257. Int J Mol Sci. 2019. PMID: 31652770 Free PMC article.
-
The effect of omega-3 fatty acids supplementation on social and behavioral disorders of children with autism: a randomized clinical trial.Pediatr Endocrinol Diabetes Metab. 2021;27(1):12-18. doi: 10.5114/pedm.2020.101806. Pediatr Endocrinol Diabetes Metab. 2021. PMID: 33599431 Free PMC article. Clinical Trial.
-
A mindfulness-based stress management program and treatment with omega-3 fatty acids to maintain a healthy mental state in hospital nurses (Happy Nurse Project): study protocol for a randomized controlled trial.Trials. 2015 Jan 31;16:36. doi: 10.1186/s13063-015-0554-z. Trials. 2015. PMID: 25636180 Free PMC article. Clinical Trial.
-
From Maternal Diet to Neurodevelopmental Disorders: A Story of Neuroinflammation.Front Cell Neurosci. 2021 Jan 15;14:612705. doi: 10.3389/fncel.2020.612705. eCollection 2020. Front Cell Neurosci. 2021. PMID: 33536875 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials